|
|
|
|
home
» programmes, assets and commercialisation
Programmes, Assets and Commercialisation
|
Our research and development programmes are controlled
by an experienced programme manager with extensive industry experience. They
ensure the research providers are progressing against pre-set milestone to
ensure the programme reaches its objectives.
Commissioning
and managing R&D programmes for ultimate commercial success is at the
heart of ITI Life Sciences' activities. To date we have commissioned six
programmes, these are listed below along with their Commercial Flyers available
to view and download.
|
•
Our R&D programmes typically
cover a 3-4 year period, during which significant intellectual assets are
realised. For more information please click here.
|
|
The key benefit for the commercialisation partner is the opportunity to take our de-risked foreground intellectual Property (IP) and develop this further to deploy in the market. For more information please click here.
We have licensing opportunities available from our programmes, please see our commercialisation flyers below for details. For any extra information on our commercial opportunities from any of our programmes please contact us.
|
A brief look at the licensing opportunities from our Cardiac BioMarkers programme, specifically in the non-human healthcare market.
Download
171 kb
A brief look at the commercial opportunities available from the Stem Cell programme.
Download
183 kb
A brief look at the potential in-vitro commercial opportunities from our transgenic models programme.
Download
106 kb
|
For more information about any of these opportunities or others from
our exciting programmes, please speak to our Director of
Commercialisation, Ford Kennedy on 01382 568060 or email enquiries to ford.kennedy@itilifesciences.com
|
|